Pharmacokinetics and metabolism of intravenous midazolam in preterm infants.

de Wildt, S N; Kearns, G L; Hop, W C; Murry, D J; Abdel-Rahman, S M; van den Anker, J N

de Wildt, S N; Kearns, G L; Hop, W C; Murry, D J; Abdel-Rahman, S M; van den Anker, J N.

Affiliation

de Wildt SN; Department of Pediatrics, Erasmus Medical Center Rotterdam, The Netherlands. sdewildt@hotmail.com

Clin Pharmacol Ther ; 70(6): 525-31, 2001 Dec.

Article in En | MEDLINE | ID: mdl-11753268

Subject(s)

Anti-Anxiety Agents/pharmacokinetics; Infant, Premature/metabolism; Midazolam/pharmacokinetics; Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Female; Gestational Age; Half-Life; Humans; Indomethacin/adverse effects; Infant, Newborn; Injections, Intravenous; Male

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Anti-Anxiety Agents / Midazolam / Infant, Premature Limits: Female / Humans / Male / Newborn Language: En Journal: Clin Pharmacol Ther Year: 2001 Type: Article Affiliation country: Netherlands

Search on Google

XML

PubMed Links